SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS
US Application 18/851,859
Filed on 2024-09-27
Filed on 2024-09-27
SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS
China
202380031329.1
Filed on 2024-09-27
202380031329.1
Filed on 2024-09-27
SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS
Australia
2023241585
Filed on 2024-10-22
2023241585
Filed on 2024-10-22
SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS
Canada
3246976
Filed on 2024-09-26
3246976
Filed on 2024-09-26
SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS
Japan
2024-556537
Filed on 2024-09-20
2024-556537
Filed on 2024-09-20
SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS
India
202417070948
Filed on 2024-09-19
202417070948
Filed on 2024-09-19
FUSED DIAZEPINES AS AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF
European Patent
23709497.4
Filed on 2024-08-22
23709497.4
Filed on 2024-08-22
FUSED DIAZEPINES AS AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF
Canada
3243968
Filed on 2024-08-09
3243968
Filed on 2024-08-09
METHODS AND SYSTEMS FOR ANALYZING TARGET ENGAGEMENT DATA
FROM BIOLOGICAL ASSAYS
European Patent
22854698.2
Filed on 2024-07-22
22854698.2
Filed on 2024-07-22
RALDH1 Inhibitors For The Immunotherapy Of Hepatocellular Carcinoma
US Application 63/452,978
Filed on 2023-03-17
Filed on 2023-03-17